Nachrichten zur Zoetis Inc. Aktie

Zoetis Stock Is About as Cheap as Its Ever Been. 1 Thing to Know Before You Buy.

Shares in animal pharmaceutical company Zoetis (NYSE: ZTS) have been under a cloud since the release of the companys fourth-quarter…

Should You Bet on PAHC Stock at a Discounted P/E of 10.41X?

PAHCs solid MFA franchise, now bolstered by Zoetis portfolio, makes it a solid investment case. A well-established foothold in key…

Zoetis (ZTS) Laps the Stock Market: Heres Why

Zoetis (ZTS) reachead $170.37 at the closing of the latest trading day, reflecting a +1.87% change compared to its last…

A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now

It is a beautiful thing when you find a feel-good stock that offers market-beating potential. A perfect example of this…

Love, Money, and Stocks

In this podcast, Motley Fool host Dylan Lewis and analysts Jason Moser and Emily Flippen break down: The Trade Desks 30%…

Zoetis gets Conditional License for Bird Flu Vaccine

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than…

Why Zoetis Stock Took Another Tumble Today

One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (NYSE: ZTS) shares again…

Zoetis gains conditional license for avian flu vaccine in chickens

…

Why Zoetis Stock Was Falling Today

Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up short…

Zoetis: Tiergesundheitsriese enttäuscht – Aktie sackt ab

Der führende Hersteller von Veterinärpharmazeutika, der US-Konzern Zoetis, hat mit den Zahlen zum vierten Quartal die Erwartungen der Analysten zwar…

Zoetis: Tiergesundheitsriese enttäuscht – Aktie sackt ab

Der führende Hersteller von Veterinärpharmazeutika, der US-Konzern Zoetis, hat mit den Zahlen zum vierten Quartal die Erwartungen der Analysten zwar…

Zoetis Aktie: Schwacher Ausblick belastet - Kurs bricht ein

Kulmbach (www.aktiencheck.de) - Zoetis-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Looking to Grow Your Passive Income in 2025? 3 Top Dividend Growth Stocks to Double Up On Right Now

Theres no way around it. Im approaching the age of 40 faster than Id like. Despite this undeniable fact, locating…

Wafaa Mamilli To Join Roche As Chief Digital Technology Officer

Wafaa Mamilli will join Roche as the companys new Chief Digital Technology Officer in February. This follows expansive roles she…

Zoetis stands out in weak animal health sector, Piper survey shows By Investing.com

Zoetis stands out in weak animal health sector, Piper survey shows…

Zoetis CEO Says Its Arthritis Drug for Dogs Is Safe

Zoetis CEO Kristen Peck talks about expanding their line of medications and she says the market for animal care products…

5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income

If youre an investor looking to grow your long-term passive income prospects, the five stocks in this article could be…

A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025

One of my favorite ways to add money to my portfolio is to invest in proven compounders with track…

Zoetis Inc. (ZTS) Piper Sandler 36th Annual Healthcare Conference (Transcript)

…

Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript)

…

1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent Pullback @themotleyfool #stocks $ZTS

Zoetis looks like a classic example of a premium business trading at a fair price following its recent dip.…

Zoetis CEO Kristin Peck on Q3: Earnings beat driven by broad portfolio

Kristin Peck, Zoetis CEO, joins Money Movers to discuss Zoetis quarterly earnings results, what allowed the company to beat earnings…

Zoetis Inc. (ZTS) Q3 2024 Earnings Call Transcript

…

Zoetis lifts full-year guidance amid strength at companion animal unit By Investing.com

Zoetis lifts full-year guidance amid strength at companion animal unit…

Zoetis raises full-year guidance on strong Q3 results

Zoetis Inc (NYSE:ZTS, ETR:ZOE) delivered another impressive quarter, with revenue and earnings exceeding Wall Street estimates for the third quarter…

Zoetis Q3 Earnings & Revenues Beat, 24 Outlook Raised, Stock Up

ZTS stock gains as third-quarter results beat both earnings and revenue estimates, driven by strong product sales. Management raises the…

PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis

Phibro successfully acquires Zoetis Inc.s MFA portfolio and certain water-soluble products.…

Wall Street Week 09/27/2024

This week, we tell a story of the prudence PNC uses in its approach to banking and serving the Pittsburgh…

Zoetis (NYSE:ZTS) investors will be pleased with their favorable 58% return over the last five years

The main point of investing for the long term is to make money. Furthermore, youd generally like to see the…

Zoetis Inc (ZTS) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)

…

Analyst Report: Zoetis Inc

…

Veterinary Diagnostic Market: $3.3B to $5.0B Growth Forecast (2023-2029) | MarketsandMarkets™

Chicago, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The "Veterinary Diagnostic Market Size, Share & Trends by Product (Instrument,…

Zoetis Q2 Earnings: Harvesting From DTC (Rating Upgrade)

…

Zoetis Inc. (ZTS) Q2 2024 Earnings Call Transcript

…

Why Zoetis Stock Was Moving Higher Tuesday

It was a classic beat-and-raise quarter for Zoetis.…

Zoetis Inc. 2024 Q2 - Results - Earnings Call Presentation

…

Zoetis (ZTS) Q2 Earnings & Revenues Beat, 24 Outlook Raised

Zoetis (ZTS) reports better-than-expected Q2 results, beating both earnings and revenue estimates, primarily driven by strong sales of companion animal…

Zoetis (ZTS) to Report Q2 Earnings: Whats in the Cards?

Zoetis (ZTS) higher companion animal product sales are expected to have driven revenues in the second quarter of 2024 in…

Global Swine Healthcare Market Size To Worth USD 5.96 Billion By 2033 | CAGR of 8.16%

The Global Swine Healthcare Market Size was Valued at USD 2.72 Billion in 2023 and the Worldwide Swine Healthcare Market…

Global Agricultural Disinfectants Market Size To Worth USD 4.41 Billion By 2033 l CAGR Of 4.43%

The Global Agricultural Disinfectants Market Size was Valued at USD 2.86 Billion in 2023 and the Worldwide Agricultural Disinfectants Market…

Analyst Report: Zoetis Inc

…

Beat the Dow Jones With This Cash-Gushing Dividend Stock

With one decade of doubling the Dow Jones total return under its belt, Zoetis looks ready to deliver another 10…

5 Biggest Pharmaceutical ETFs in 2024

The global pharmaceutical market reached a total value of US$1.6 trillion in 2023, according to Statista, up significantly from the…

Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets – Hagens Berman

SAN FRANCISCO, May 16, 2024 (GLOBE NEWSWIRE) -- Hagens Berman is urging investors who suffered substantial losses in…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS

NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

Bragar Eagel & Squire, P.C. Is Investigating Zoetis, and Morgan Stanley and Encourages Investors to Contact the Firm

NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS

NEW YORK, May 04, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

dpa-AFX ProFeed